drugset / Trial / NCT04716699
Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
Phase 1
Completed
12 enrolled
University of California, Davis
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelBasic science
Summary
This clinical trial measures the amount and effect of lidocaine injected into patients with glioblastoma while they are undergoing surgical removal of their brain tumors. Lidocaine is a substance used to relieve pain by blocking signals at the nerve endings in skin. Information gained from this study may help researchers come up with new treatments to help patients with glioblastomas in the future.
Timeline
- Start
- 2021-01-20
- Primary completion
- 2021-12-26
- Completion
- 2022-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 mg/kg | Intravenous |